Scrip: industry news and insights
Executives On The Move: Jubilant, Mithra And More
02 Jun 2023
Recent executive moves in the industry include C-suite changes at Jubilant Pharmova and Sanofi. Meanwhile, new directors were appointed at...
Pfizer Inc., GlaxoSmithKline PLC, Allergan PLC and Eli Lilly & Co. are among big pharma firms facing generic competition to blockbuster brands, while AbbVie Inc. and Roche have got biosimilar rivals to worry about.
New drug launches have increased over the past couple of years, but few have reached blockbuster status yet. Meanwhile, China’s increasing appetite (and willingness to pay) for therapeutic innovation was a positive for several big pharma companies in the first quarter. Scrip’s webinar takes a deep dive into the key issues and trends emerging from industry earnings calls.
Scrip: industry news and insights
02 Jun 2023
Recent executive moves in the industry include C-suite changes at Jubilant Pharmova and Sanofi. Meanwhile, new directors were appointed at...
Scrip: industry news and insights
By Ayisha Sharma 02 Jun 2023
An increasing number of biotech companies originating from the US and Asia are building EU headquarters in Switzerland. Scrip spoke...
Scrip: industry news and insights
By Anju Ghangurde 02 Jun 2023
Alkem’s ‘affordable’ cetuximab biosimilar set to take on Erbitux in India, even as Merck KGaA pursues a court case seeking...
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: